Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 12, No 3 (2020)

Articles

Dear colleagues and readers!

Kotenko O.N.
Clinical nephrology. 2020;12(3):3-3
pages 3-3 views

O RABOTE PREZIDIUMA PROFIL'NOY KOMISSII

Shilov E.M.
Clinical nephrology. 2020;12(3):4-4
pages 4-4 views

Life on hemodialysis: patients’ look into the future

Popov E.A.

Abstract

Objective. to analyze the views of patients on hemodialysis (HD) to address the issue of minimizing the consequences of social adaptation of patients to the procedure itself and to the difficult life situation in which they find themselves. material and methods. sociological survey of patients on hd (2018-2019) in the Altai territory (n=148), the Altai republic (n=84). results. it was found that most patients remain optimistic and have serious life plans for the future. at the same time, it is noted that patients increasingly perceive the hd procedure not as a heavy burden and a painful type of medical intervention, but as salvation and hope for the future. the analysis of the gender and age characteristics of the recipients, as well as their occupation, made it possible to differentiate the ideas about the future of patients, to assess the involvement of a serious illness in their daily life and the formation of life prospects. Conclusion. an important feature of the patients’ individual perception of their disease and its impact on the social well-being of people was revealed.
Clinical nephrology. 2020;12(3):6-9
pages 6-9 views

Comparative evaluation of the structure of cardiovascular diseases of the rural and urban population of the republic of uzbekistan, suffering from stage 5 CKD on programmed hemodialysis

Sharapov O.N., Daminov B.T., Yarygina S.V., Dyagilev V.A.

Abstract

Objective. comparatively study the structure of cardiovascular pathology in patients with stage 5 ckd receiving programmed hemodialysis of the rural and urban population of the republic of Uzbekistan. material and methods. 165 patients with stage 5 ckd receiving hemodialysis were examined. patients were divided into two groups depending on their permanent place of residence: urban and rural. the study of patients from the urban population was carried out in two large republican centers in Tashkent and the rural population was studied in the regional multidisciplinary medical center in the city of gulistan. results. According to the results of the study, cardiovascular pathology was determined in 60% of the urban and 39% of the rural population. ah, ihd and hf prevailed in its structure in both groups. also, cvs comorbidity was found in both groups. Conclusion. According to the results of our study, patients in the urban population with CKD5D are more likely to suffer from cardiovascular disease than in the rural population. Comorbid cvs pathology occupies a leading place in the structure of cardiovascular pathology in patients with CKD5D in both urban and rural populations.
Clinical nephrology. 2020;12(3):10-14
pages 10-14 views

Social support for ckd patients on dialysis in an inpatient social institution

Yakunin A.V., Sheykhov M.R., Kotenko O.N., Kondrashova L.M., Vasina N.V.

Abstract

The presented article discusses and proposes a solution to the problem of lonely and of disabled patients with limited mobility who need treatment with programmed hemodialysis. According to the results of the survey of patients on programmed hemodialysis, a typical portrait of ckd patient with limited mobility who was on dialysis was identified. They are mostly 66-year-old man or 65-year-old woman. of all the respondents undergoing the hd procedure, 92% have concomitant diseases and 80% of them use the transportation service to the hemodialysis procedure. it was confirmed that if there was an opportunity to live in a habilitation with all social services and hd without transportation, 21% of the respondents with limited mobility would like to take advantage of this. based on the analysis of the questionnaire survey of ckd patients with limited mobility who are on hd, it can be concluded that there are at least 60 patients in Moscow (1.5% of the total number of patients on programmed hemodialysis) who live alone, have an income below average and do not have children and relatives. They are ready to live in a social institution with hd and are ready to pay 75% of their average income for this.
Clinical nephrology. 2020;12(3):15-21
pages 15-21 views

Renal function and cytokine profile changes with COVID-19

Murkamilov I.T., Aitbaev K.A., Fomin V.V., Kudaibergenova I.O., Murkamilova Z.A., Yusupov F.A.

Abstract

Purpose. To analyze the functional state of the kidneys and changes in the cytokine profile in a new coronavirus disease (CO-VID-19). material and methods. a cross-sectional study of 177 patients (96 men and 81 women) with an established diagnosis of covid-19 and pneumonia was carried out. the average age of the examined persons was 48.8±15.2 years. the indices of the calculated glomerular filtration rate (egfr) by blood creatinine were studied, and a single portion of morning urine was analyzed. in 101 (57,0%) patients, the parameters of the cytokine blood profile, including interleukin (IL)-6, -io and tumor necrosis factor alpha (TNF-а), were examined. results. in the examined group of patients with covid-19 and pneumonia, the presence of respiratory failure was noted in 41 (23.i%) patients, anemia - in 32 (18.o%), elevated levels of c-reactive protein and cytokines - in 125 (70.6%) and 31 (30.6%), respectively. a decrease in egfr<60 ml/min/1.73 m2 was found in 13 (7.з%) patients, a severe decrease in gfr - in 9 (5.o%) patients. an insignificant and moderate slowdown in gfr was noted in 22.o and 1.1% of cases, respectively. the optimal egfr level was observed in 125 (70.6%) patients. In the structure of urinary syndrome, persons with hematuria (n=135, 76.2%) and proteinuria (n=57, 32.2%) prevailed. in the urinary sediment of 15 (8.4%) patients, renal epithelial cells were detected. the concentration of il-6 positively correlated with the level of crp and fibrinogen, negatively - with the levels of hemoglobin, hematocrit, the number of erythrocytes, the average hemoglobin content in erythrocytes, and the relative number of lymphocytes. a direct relationship TNF-а concentration was observed with platelet count, absolute lymphocyte count, and proteinuria. An increase in TNF-а concentration was inversely correlated with a decrease in egfr and urine ph. a close relationship was demonstrated between the concentration of crp in the blood and the value of egfr. Conclusions. in patients with covid-19 and sars, hematuria and proteinuria are most commonly reported. among the study participants, 125 (70.6%) patients had optimal renal function. in general, an egfr value of <89 ml/min/1.73 m2 was recorded in 52 (29.3%) patients, WHILE IN 13 (7.3%) THE EGFR LEVEL WAS <60 MUMIN/1.73 M2. TNF-а IS A SIGNIFICANT CYTOKINE THAT AFFECTS THE indicators of renal filtration function and proteinuria.
Clinical nephrology. 2020;12(3):22-30
pages 22-30 views

The efficacy and safety of the sucroferric oxyhydroxide (Velphoro®) in hemodialysis patients: results of a prospective randomized controlled trial

Shutov E.V., Kotlyarova G.V., Lysenko K.M., Ryabinskaya G.V., Lashutin S.V.

Abstract

The treatment of hyperphosphatemia is the main goal in cure of mineral and bone disorders in patients with ckd. however, the results of the correction of hyperphosphatemia remain unsatisfactory. This is due to the absence of effective and safe medicines. in our prospective randomized controlled trial we evaluated the effects of a 16-week treatment with a new phosphate binder -sucroferric oxyhydroxide (velphoro®) in comparison with sevelamer carbonate (‘sevelamer’) on ckd-mbd parameters in patients on chronic hemodialysis with hyperphosphatemia. materials and methods. after 4-week washout period from previous phosphate binders, 50 stable patients with hyperphosphatemia (P>5,5 mg/dl) were randomized at a 1:1 ratio to receive sucroferric oxyhydroxide (n=25) or sevelamer (n=25) for treatment up to 16 weeks. in all patients levels of p, ca, pth, ferritin, transferrin saturation, hb, fgf-23, crp were monthly evaluated. the dose of both medications was adjusted according to serum phosphate level. results: Phosphate binder therapy of sucroferric oxyhydroxide was associated with a significant decrease in serum phosphate level from 6,8±1,5 to 5,27±0,99 mg/dl (P<0,01); HOWEVER, TREATMENT with sevelamer did not reduce the level of P: 6,32±1,5 vs 6,35±1,9 mg/dl. the number of prescribed tablets was lower in the sucroferric oxyhydroxide group (2,o ±i,5 tab/day, mean ± sd) compared with sevelamer group (6,1±з,2 tab/day, mean±sd). the average intact fibroblast growth factor-23 (fgf-23), pth, transferrin saturation and ferritin levels did not significantly change in both groups. we noted also in velphoro group increase in Hb level from io5,6±15,7 to 111,9±22,з g/l (p<0,05) by the end of the study and simultaneously decrease in crp level by 50% (p<0,01). during the study, 6 patients in the sucroferric oxyhydroxide group and 5 in the sevelamer group dropped out due to dyspeptic symptoms. Conclusions. Sucroferric oxyhydroxide (Velphoro®) is a new more effective phosphate binder with a comparable safety profile to a sevelamer, but with superioir phosphate binding capacity.treatment with velphoro can significantly increase the level of hb and reduce level of inflammation.
Clinical nephrology. 2020;12(3):31-36
pages 31-36 views

Ezetimibe in chronic kidney disease: an effect on the risk of developing cardiovascular and cerebral complications

Murkamilov I.T., Sabirov L.S., Fomin V.V., Murkamilova Z.A., Yusupov F.A., Redzhapova N.A., Rayimzhanov Z.R.

Abstract

The article discusses the effectiveness and safety of lipid-lowering therapy in patients with cardiovascular and renal diseases. attention is focused on an inhibitor of cholesterol absorption in the small intestine - ezetimibe. Data on the hypolipidemic and anti-inflammatory effects of ezetimibe and its combination with statins are summarized. Ezetimibe has been shown to have a good safety profile, significantly reducing cardiovascular and cerebral risk, as well as the progression of chronic kidney disease.
Clinical nephrology. 2020;12(3):37-44
pages 37-44 views

Differential diagnosis of thrombotic microangiopathies. Program

- -.
Clinical nephrology. 2020;12(3):45-45
pages 45-45 views
pages 46-52 views
pages 53-54 views

Routing of patients with newly diagnosed atypical hemolytic uremic syndrome

Vasina N.V., Kotenko O.N.
Clinical nephrology. 2020;12(3):55-56
pages 55-56 views

Aleksey Yur'yevich Nikolayev

- -.
Clinical nephrology. 2020;12(3):57-57
pages 57-57 views

USTAV STOLIChNOY ASSOTsIATsII VRAChEY-NEFROLOGOV

- -.
Clinical nephrology. 2020;12(3):58-62
pages 58-62 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies